Market Open
S&P 500 $745.64 +0.39% DOW $506.12 +0.60% NASDAQ $717.54 +0.42% BTC $77,512 +1.46%
ALNY
Alnylam Pharmaceuticals Inc
NASDAQ HEALTHCARE
$297.45
$-3.06 (-1.02%)
Delayed 15 min · May 25, 4:35 PM UTC
Open
$0.00
High
$0.00
Low
$0.00
Prev Close
$0.00
Volume
681.31K

Price Chart

About Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts.

📊 HEALTHCARE 🏭 BIOTECHNOLOGY 🌍 USA

ALNY News

Assessing Alnylam Pharmaceuticals (ALNY) Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake
Simply Wall Street • 2d ago
Assessing Alnylam Pharmaceuticals (ALNY) Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake
Simply Wall Street • 2d ago Somewhat-Bullish
Alnylam (ALNY) director gets new RSUs, options and reports trust holdings
Stock Titan • 2d ago
Alnylam (ALNY) director granted RSUs and stock options in new equity awards
Stock Titan • 2d ago
Director Peter Kellogg granted RSUs and stock options at Alnylam (NASDAQ: ALNY)
Stock Titan • 2d ago
Alnylam (NASDAQ: ALNY) awards RSUs and options to board director
Stock Titan • 2d ago
Discipline and Rules-Based Execution in ALNY Response
Stock Traders Daily • 3d ago Somewhat-Bullish
Alnylam Q1 Earnings Beat Estimates, Amvuttra Sales Drive Y/Y Growth
Eastern Progress • 4d ago Bullish

Key Statistics

Market Cap
39.71B
P/E Ratio
74.55
EPS
$3.99
Beta
0.302
52W High
$495.55
52W Low
$284.28
Div Yield
N/A
Avg Volume
681.31K

Related Stocks

AAPL
Apple
MSFT
Microsoft
GOOGL
Alphabet
AMZN
Amazon
TSLA
Tesla

💬 Discussion

Loading...
Loading comments...